Bristol-Myers Squibb Company

NYSE: BMY
$58.38
-$0.40 (-0.7%)
Real Time Data Delayed 15 Min.

BMY Articles

Judging by this report, short sellers are making a tremendous bet against Trump’s plan to reform the health care sector.
Tuesday, February 21, 2017, saw three large companies in the news after activist investors have targeted them. Investors have taken mixed reactions to each effort.
2016's 50 most innovative companies are topped by Apple, Google and Tesla. Among the companies making the biggest moves were Netflix and Facebook, and new entrants on the list included Uber and...
It has yet to be seen how much headway Trump can actually make with heath care reforms, but so far the reaction has been quite positive.
Bristol-Myers, Mattel, DryShips, and FuelCell Energy posted new 52-week lows Thursday.
The January 13 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mostly down.
Bristol-Myers, DryShips, Michaels, and Meridian Bioscience sink into Wednesday's 52-week low club.
The health care sector has some of its biggest players reporting later this week, with one pharma giant’s report already out of the way.
Bristol-Myers, DryShips, Target, and Fitbit posted new 52-week lows on Friday.
The top analyst upgrades, downgrades and initiations seen on Friday include Alphabet, Amazon, Bristol-Myers, CBS, Check Point, CSX, Facebook and PayPal.
The short interest data have been released for the December 30 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through...
The December 15 short interest data have been compared with the previous figures, and short interest increased in most of these selected pharmaceutical stocks.
Portola Pharmaceuticals shares saw a handy gain on Monday after it was reported that the company had received a key loan.
Monday’s top analyst upgrades, downgrades and initiations include Anadarko Petroleum, Bristol-Myers Squibb, Comcast, Walt Disney and Merck.
The November 30 short interest data have been compared with the previous figures, and short interest decreased in these selected pharmaceutical stocks.